These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 11232701)
1. Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results. Berenguer M; Prieto M; Rayón M; Bustamante M; Carrasco D; Moya A; Pastor MA; Gobernado M; Mir J; Berenguer J Am J Gastroenterol; 2001 Feb; 96(2):526-33. PubMed ID: 11232701 [TBL] [Abstract][Full Text] [Related]
2. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study. Manns MP; Neuhaus P; Atkinson GF; Griffin KE; Barnass S; Vollmar J; Yeang Y; Young CL; Transpl Infect Dis; 2001 Mar; 3(1):16-23. PubMed ID: 11429035 [TBL] [Abstract][Full Text] [Related]
3. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss. de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278 [TBL] [Abstract][Full Text] [Related]
4. Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation. Rayes N; Seehofer D; Bechstein WO; Müller AR; Berg T; Neuhaus R; Neuhaus P Clin Transplant; 1999 Dec; 13(6):447-52. PubMed ID: 10617232 [TBL] [Abstract][Full Text] [Related]
5. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation. Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203 [TBL] [Abstract][Full Text] [Related]
6. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Krüger M; Tillmann HL; Trautwein C; Bode U; Oldhafer K; Maschek H; Böker KH; Broelsch CE; Pichlmayr R; Manns MP Liver Transpl Surg; 1996 Jul; 2(4):253-62. PubMed ID: 9346658 [TBL] [Abstract][Full Text] [Related]
7. Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial. Wedemeyer H; Böker KH; Pethig K; Petzold DR; Flemming P; Tillmann HL; Vollmar J; Bastürk M; Goldmann E; Griffin KE; Haverich A; Manns MP Transplantation; 1999 Nov; 68(10):1503-11. PubMed ID: 10589947 [TBL] [Abstract][Full Text] [Related]
8. Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation. Zheng SS; Wu J; Liang TB; Wang WL; Huang DS; Xu X Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):327-9. PubMed ID: 14607701 [TBL] [Abstract][Full Text] [Related]
9. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases]. Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673 [TBL] [Abstract][Full Text] [Related]
10. Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir. Han SH; Kinkhabwala M; Martin P; Holt C; Murray N; Seu P; Rudich S; Hiserodt D; Imagawa D; Busuttil RW Am J Gastroenterol; 1998 Nov; 93(11):2245-7. PubMed ID: 9820407 [TBL] [Abstract][Full Text] [Related]
11. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation. Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032 [TBL] [Abstract][Full Text] [Related]
12. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation. Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394 [TBL] [Abstract][Full Text] [Related]
13. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance. Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436 [TBL] [Abstract][Full Text] [Related]
14. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation. Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803 [TBL] [Abstract][Full Text] [Related]
15. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation. Fontana RJ; Hann HW; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Riker-Hopkins M; Brown N; Liver Transpl; 2001 Jun; 7(6):504-10. PubMed ID: 11443577 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children. Shapira R; Mor E; Bar-Nathan N; Sokal EM; Tur-Kaspa R; Dinari G; Ben-Ari Z Transplantation; 2001 Jul; 72(2):333-6. PubMed ID: 11477362 [TBL] [Abstract][Full Text] [Related]
17. Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up. Yoshida EM; Ma MM; Davis JE; Fischer KP; Kneteman NM; Erb SR; Tyrrell DL; Bain VG Can J Gastroenterol; 1998 Mar; 12(2):125-9. PubMed ID: 9559207 [TBL] [Abstract][Full Text] [Related]